PCTY's first-quarter fiscal 2025 results reflect improved earnings and revenues, owing to its sustained focus on scaling operational costs and...
Vous n'êtes pas connecté
SYY's Q1 2025 results reflect improved earnings and revenues. It projects a 4-5% increase in sales and 6-7% adjusted EPS growth for fiscal 2025.
PCTY's first-quarter fiscal 2025 results reflect improved earnings and revenues, owing to its sustained focus on scaling operational costs and...
RCI's third-quarter 2024 results reflect revenue growth in Media businesses, driven by higher sports-related revenues.
CMPR's fiscal first-quarter organic constant-currency revenues increase 6% year over year, driven by growth across each of its businesses.
CL's Q3 results reflect continued gains from volume and pricing, which led to organic sales growth in five of six divisions. Improved margins aid EPS...
Cardinal Health's first-quarter fiscal 2025 results benefit from solid Pharmaceutical and Specialty Solutions growth. However, OptumRx contract expiry...
CACI's Q1 results benefit from higher revenues, improved operating income and reduced share counts, partially offset by a higher tax provision.
GE's third-quarter 2024 results reflect a 6% y/y increase in revenues, driven by the solid performances of its segments.
BALL's s third-quarter 2024 results reflect improved segment margins. The company expects to deliver more than mid-single-digit comparable EPS growth...
BRO's Q3 results reflect improved organic revenues, driven by higher commission and fees and investment income, expanded EBITDAC margin and increased...
BHC's third-quarter adjusted earnings and revenues beat estimates. The increase in revenue guidance is positive.